GB0004269D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0004269D0
GB0004269D0 GB0004269A GB0004269A GB0004269D0 GB 0004269 D0 GB0004269 D0 GB 0004269D0 GB 0004269 A GB0004269 A GB 0004269A GB 0004269 A GB0004269 A GB 0004269A GB 0004269 D0 GB0004269 D0 GB 0004269D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0004269A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GB0004269A priority Critical patent/GB0004269D0/en
Publication of GB0004269D0 publication Critical patent/GB0004269D0/en
Priority to AU5615601A priority patent/AU5615601A/xx
Priority to DK01929345.5T priority patent/DK1265915T3/da
Priority to DK06075141.9T priority patent/DK1650221T3/da
Priority to MXPA02008279A priority patent/MXPA02008279A/es
Priority to AT01929345T priority patent/ATE487733T1/de
Priority to KR1020087004445A priority patent/KR100919916B1/ko
Priority to EP06075141A priority patent/EP1650221B1/en
Priority to IL15109701A priority patent/IL151097A0/xx
Priority to JP2001562559A priority patent/JP5502253B2/ja
Priority to PT06075141T priority patent/PT1650221E/pt
Priority to CNB018084117A priority patent/CN1254541C/zh
Priority to PT01929345T priority patent/PT1265915E/pt
Priority to CZ20022874A priority patent/CZ303468B6/cs
Priority to ES01929345T priority patent/ES2355129T3/es
Priority to NZ520673A priority patent/NZ520673A/en
Priority to KR1020097013427A priority patent/KR20090085697A/ko
Priority to DE60143425T priority patent/DE60143425D1/de
Priority to SI200130986T priority patent/SI1265915T1/sl
Priority to SI200131014T priority patent/SI1650221T1/sl
Priority to BR0108654-5A priority patent/BR0108654A/pt
Priority to KR1020027010961A priority patent/KR100848973B1/ko
Priority to HU0300054A priority patent/HUP0300054A3/hu
Priority to PCT/EP2001/001779 priority patent/WO2001062778A2/en
Priority to CN200610068150.1A priority patent/CN1840178B/zh
Priority to EP01929345A priority patent/EP1265915B1/en
Priority to AU2001256156A priority patent/AU2001256156B2/en
Priority to CA2400842A priority patent/CA2400842C/en
Priority to PL362698A priority patent/PL209127B1/pl
Priority to CN 200610068140 priority patent/CN1879877A/zh
Priority to ES06075141T priority patent/ES2389445T3/es
Priority to IL151097A priority patent/IL151097A/en
Priority to ZA200206746A priority patent/ZA200206746B/en
Priority to NO20024002A priority patent/NO332141B1/no
Priority to US10/226,872 priority patent/US20030157118A1/en
Priority to HK06111131.1A priority patent/HK1093513A1/xx
Priority to HK03103646.9A priority patent/HK1052710A1/xx
Priority to US10/650,608 priority patent/US7811574B2/en
Priority to US11/301,895 priority patent/US7803379B2/en
Priority to AU2006201042A priority patent/AU2006201042B2/en
Priority to US12/400,449 priority patent/US20100291121A1/en
Priority to US12/860,020 priority patent/US8207123B2/en
Priority to CY20111100086T priority patent/CY1111156T1/el
Priority to US13/472,035 priority patent/US8535690B2/en
Priority to CY20121100829T priority patent/CY1113109T1/el
Ceased legal-status Critical Current

Links

GB0004269A 2000-02-23 2000-02-23 Novel compounds Ceased GB0004269D0 (en)

Priority Applications (45)

Application Number Priority Date Filing Date Title
GB0004269A GB0004269D0 (en) 2000-02-23 2000-02-23 Novel compounds
DK01929345.5T DK1265915T3 (da) 2000-02-23 2001-02-16 Nye forbindelser
HU0300054A HUP0300054A3 (en) 2000-02-23 2001-02-16 Tumour-specific animal proteins
CN200610068150.1A CN1840178B (zh) 2000-02-23 2001-02-16 肿瘤特异性动物蛋白
DK06075141.9T DK1650221T3 (da) 2000-02-23 2001-02-16 Nye forbindelser
PCT/EP2001/001779 WO2001062778A2 (en) 2000-02-23 2001-02-16 Tumour-specific animal proteins
AT01929345T ATE487733T1 (de) 2000-02-23 2001-02-16 Neue verbindungen
KR1020087004445A KR100919916B1 (ko) 2000-02-23 2001-02-16 종양 특이적 동물 단백질
EP06075141A EP1650221B1 (en) 2000-02-23 2001-02-16 Novel compounds
IL15109701A IL151097A0 (en) 2000-02-23 2001-02-16 Tumour-specific animal proteins
JP2001562559A JP5502253B2 (ja) 2000-02-23 2001-02-16 新規化合物
PT06075141T PT1650221E (pt) 2000-02-23 2001-02-16 Novos compostos
CNB018084117A CN1254541C (zh) 2000-02-23 2001-02-16 新化合物
PT01929345T PT1265915E (pt) 2000-02-23 2001-02-16 Novos compostos
CZ20022874A CZ303468B6 (cs) 2000-02-23 2001-02-16 Imunogenní smes a farmaceutická smes
ES01929345T ES2355129T3 (es) 2000-02-23 2001-02-16 Compuestos novedosos.
NZ520673A NZ520673A (en) 2000-02-23 2001-02-16 Tumour-specific animal proteins
KR1020097013427A KR20090085697A (ko) 2000-02-23 2001-02-16 종양 특이적 동물 단백질
DE60143425T DE60143425D1 (de) 2000-02-23 2001-02-16 Neue verbindungen
EP01929345A EP1265915B1 (en) 2000-02-23 2001-02-16 Novel compounds
SI200131014T SI1650221T1 (sl) 2000-02-23 2001-02-16 Nove spojine
BR0108654-5A BR0108654A (pt) 2000-02-23 2001-02-16 Composição imunogênica, polipeptìdeo isolado, vetor de expressão ou um microorganismo vivo recombinante, célula hospedeira, processos para produzir uma composição imunogênica e um polipeptìdeo ou um fragmento imunogênico do mesmo, uso de um polipeptìdeo ou de um polinucleotìdeo que codifica um polipeptìdeo, método para o tratamento de um indivìduo pela imunoprofilaxia ou terapia, anticorpo, agonista ou antagonista ao polipeptìdeo, composto, e, processos para diagnosticar, uma doença ou uma suscetibilidade a uma doença e a presença de câncer colorretal ou uma suscetibilidade ao câncer colorretal, em um indivìduo
KR1020027010961A KR100848973B1 (ko) 2000-02-23 2001-02-16 종양 특이적 동물 단백질
AU5615601A AU5615601A (en) 2000-02-23 2001-02-16 Novel compounds
MXPA02008279A MXPA02008279A (es) 2000-02-23 2001-02-16 Proteinas animales especificas de tumor.
ES06075141T ES2389445T3 (es) 2000-02-23 2001-02-16 Compuestos novedosos
SI200130986T SI1265915T1 (sl) 2000-02-23 2001-02-16 Nove spojine
AU2001256156A AU2001256156B2 (en) 2000-02-23 2001-02-16 Novel compounds
CA2400842A CA2400842C (en) 2000-02-23 2001-02-16 Novel compounds
PL362698A PL209127B1 (pl) 2000-02-23 2001-02-16 Środek farmaceutyczny do stosowania w immunoterapeutycznym leczeniu raka i sposób diagnozowania u pacjenta obecności lub podatności na raka
CN 200610068140 CN1879877A (zh) 2000-02-23 2001-02-16 肿瘤特异性动物蛋白
IL151097A IL151097A (en) 2000-02-23 2002-08-06 An immunogenic preparation comprising CASB7439 polypeptide and its use in the manufacture of a vaccine for the treatment of diseases related to the colon
NO20024002A NO332141B1 (no) 2000-02-23 2002-08-22 Immunogen sammensetning samt farmasoytisk sammensetning og deres anvendelse
ZA200206746A ZA200206746B (en) 2000-02-23 2002-08-22 Tumour-specific animal proteins.
US10/226,872 US20030157118A1 (en) 2000-02-23 2002-08-23 Tumour-specific animal proteins
HK03103646.9A HK1052710A1 (en) 2000-02-23 2003-05-22 Novel compounds
HK06111131.1A HK1093513A1 (en) 2000-02-23 2003-05-22 Novel compounds
US10/650,608 US7811574B2 (en) 2000-02-23 2003-08-28 Tumour-specific animal proteins
US11/301,895 US7803379B2 (en) 2000-02-23 2005-12-13 Tumour-specific animal proteins
AU2006201042A AU2006201042B2 (en) 2000-02-23 2006-03-10 Novel compounds
US12/400,449 US20100291121A1 (en) 2000-02-23 2009-03-09 Tumour-Specific Animal Proteins
US12/860,020 US8207123B2 (en) 2000-02-23 2010-08-20 Tumour-specific animal proteins
CY20111100086T CY1111156T1 (el) 2000-02-23 2011-01-28 Νεες ενωσεις
US13/472,035 US8535690B2 (en) 2000-02-23 2012-05-15 Tumor specific animal proteins
CY20121100829T CY1113109T1 (el) 2000-02-23 2012-09-12 Νεες ενωσεις

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0004269A GB0004269D0 (en) 2000-02-23 2000-02-23 Novel compounds

Publications (1)

Publication Number Publication Date
GB0004269D0 true GB0004269D0 (en) 2000-04-12

Family

ID=9886246

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0004269A Ceased GB0004269D0 (en) 2000-02-23 2000-02-23 Novel compounds

Country Status (4)

Country Link
CN (2) CN1879877A (zh)
ES (1) ES2355129T3 (zh)
GB (1) GB0004269D0 (zh)
ZA (1) ZA200206746B (zh)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300883A (es) * 1992-02-18 1994-08-31 Smithkline Beecham Corp Polipeptidos de vacuna.

Also Published As

Publication number Publication date
CN1879877A (zh) 2006-12-20
ES2355129T3 (es) 2011-03-23
CN1840178B (zh) 2014-05-28
ZA200206746B (en) 2003-11-24
CN1840178A (zh) 2006-10-04

Similar Documents

Publication Publication Date Title
AU7476301A (en) Novel compounds
EP1276755A4 (en) NEW COMPOUNDS
GB0003019D0 (en) Novel compounds
AU9261901A (en) Novel compounds
EP1255771A4 (en) NEW COMPOUNDS
GB0008464D0 (en) Novel compounds
EP1292617A4 (en) Novel compounds
EP1472352A4 (en) NEW COMPOUNDS
EP1343813A4 (en) NEW COMPOUNDS
AU7476401A (en) Novel compounds
EP1276866A4 (en) NEW COMPOUNDS
GB0004149D0 (en) Novel compounds
EP1299530A4 (en) NEW COMPOUNDS
GB0003636D0 (en) Novel compounds
GB0001898D0 (en) Novel compounds
GB0004196D0 (en) Novel compounds
GB0002402D0 (en) Novel compounds
EG22332A (en) Novel compounds
GB0008260D0 (en) Novel compounds
GB0002096D0 (en) Novel compounds
GB0001936D0 (en) Novel compounds
GB0008421D0 (en) Novel compounds
GB0006132D0 (en) Novel compounds
GB0001550D0 (en) Novel compounds
GB0008807D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)